Comprehensive medication guide to Lamotrigine including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$30 copay for generic lamotrigine on most commercial and Medicare Part D plans; Tier 1–2 on most formularies. Brand-name Lamictal is typically not covered by Medicare Part D. Prior authorization is rarely required for the generic formulation.
Estimated Cash Pricing
$10–$47 retail for generic lamotrigine IR tablets; as low as $4.04 with a GoodRx coupon at participating pharmacies for a 30-day supply. Extended-release (XR) averages $341 retail and as low as $16.20 with GoodRx.
Medfinder Findability Score
82/100
Summarize with AI
On this page
Lamotrigine (brand name Lamictal, also sold as Subvenite) is an anticonvulsant (anti-seizure) medication that also serves as a mood stabilizer for bipolar disorder. First approved by the FDA in 1994, it is on the World Health Organization's List of Essential Medicines and is one of the most widely prescribed medications in the United States — ranking as the most commonly prescribed mood stabilizer and the 59th most prescribed drug overall in 2023, with more than 10 million annual prescriptions.
Lamotrigine is a phenyltriazine, making it chemically distinct from other anticonvulsants such as valproate, carbamazepine, or levetiracetam. It is FDA-approved for epilepsy (focal seizures, primary generalized tonic-clonic seizures, Lennox-Gastaut syndrome seizures in patients aged 2 and older) and for bipolar I disorder maintenance treatment in adults. It is also frequently prescribed off-label for major depressive disorder and acute bipolar depression.
Generic lamotrigine is widely available and significantly more affordable than brand-name Lamictal. It comes in immediate-release tablets (25 mg, 100 mg, 150 mg, 200 mg), chewable tablets, orally disintegrating tablets (ODT), extended-release (XR) tablets, and an oral suspension (Subvenite, 10 mg/mL) approved in September 2025.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Lamotrigine works primarily by stabilizing voltage-sensitive sodium channels in neurons. These channels control the electrical signals (action potentials) that neurons use to communicate. In epilepsy, neurons fire in a runaway, uncoordinated pattern that spreads through the brain as a seizure. Lamotrigine makes it harder for sodium channels to reopen quickly after firing, dampening this pathological rapid-firing without fully suppressing normal neuronal activity.
Lamotrigine also inhibits voltage-gated calcium channels, which control the release of neurotransmitters at the synapse. By blocking these channels, lamotrigine reduces the release of excitatory neurotransmitters — particularly glutamate and aspartate — that drive seizure propagation. This dual mechanism sets lamotrigine apart from GABA-enhancing anticonvulsants like phenobarbital.
For bipolar disorder, the same mechanisms appear to stabilize mood cycling by reducing glutamate-driven excitability in limbic brain regions associated with emotion regulation. Lamotrigine is particularly effective at preventing depressive episodes in bipolar disorder — more so than manic episodes — which distinguishes it from other mood stabilizers like lithium and valproate.
25 mg — immediate-release tablet
Starting dose for most patients; also used during initial titration phase
100 mg — immediate-release tablet
Common maintenance dose tablet; most widely stocked at pharmacies
150 mg — immediate-release tablet
Maintenance dose option
200 mg — immediate-release tablet
Common higher maintenance dose; maximum recommended daily dose often 200-400 mg
2 mg / 5 mg / 25 mg — chewable dispersible tablet (CD)
Low-dose starter tablets for initial titration; can be swallowed, chewed, or dissolved in liquid
25 mg / 50 mg / 100 mg / 200 mg — orally disintegrating tablet (ODT)
Dissolves on the tongue; for patients with swallowing difficulties
25 mg / 50 mg / 100 mg / 200 mg / 250 mg / 300 mg — extended-release tablet (XR)
Once-daily dosing; for adults and children 13+ with focal or generalized tonic-clonic seizures
10 mg/mL — oral suspension (Subvenite)
FDA-approved September 2025; for young children and patients unable to swallow tablets; distribution still expanding
Standard lamotrigine immediate-release tablets are generally widely available at most US pharmacies. Lamotrigine is not on the FDA's national drug shortage database as of 2026, and multiple generic manufacturers produce it, providing supply redundancy. However, this availability picture is not uniform across all formulations or all pharmacy locations.
Patients regularly encounter localized stock-outs, especially for orally disintegrating tablets (ODT), extended-release (XR) tablets, and the new oral suspension (Subvenite, approved September 2025). International supply disruptions (documented in Canada and Australia in 2024-2025) can affect US generic supply chains. In a UK study, 65.2% of epilepsy patients reported experiencing a lamotrigine shortage at some point.
Because missing lamotrigine doses can cause life-threatening seizures, finding it quickly when your pharmacy is out of stock is essential. medfinder calls pharmacies near you to identify which ones have your specific formulation and dose in stock, sending you the results by text — so you don't have to spend hours on hold.
Because lamotrigine is not a DEA-scheduled controlled substance, any licensed prescriber can write a lamotrigine prescription without special registration or waiver. This makes it broadly accessible across healthcare settings.
Neurologists / Epileptologists — Primary prescribers for epilepsy; epileptologists have subspecialty training in seizure disorders
Psychiatrists — Primary prescribers for bipolar disorder indication; experienced with titration nuances
Primary Care Physicians (PCPs) / Internists — Often manage stable lamotrigine prescriptions for bipolar disorder and simple epilepsy cases
Nurse Practitioners (NPs) and Physician Assistants (PAs) — Full prescriptive authority in most states; commonly prescribe in neurology, psychiatry, and primary care settings
Pediatricians / Pediatric Neurologists — For children with epilepsy aged 2 and older; pediatric neurologists familiar with weight-based pediatric dosing protocols
Telehealth prescribing is widely available for lamotrigine in 2026. Bipolar disorder maintenance is routinely managed via telepsychiatry platforms. Initial epilepsy evaluation typically requires in-person neurology visit; however, ongoing prescription management and refills can often be handled remotely.
No. Lamotrigine is not classified as a controlled substance by the DEA. It has no scheduling under the Controlled Substances Act. This means any licensed prescriber — including primary care physicians, nurse practitioners, physician assistants, neurologists, and psychiatrists — can prescribe it without special DEA registration. There are no federal restrictions on the number of refills, and it can be prescribed electronically via telehealth without special waiver requirements.
Because lamotrigine is not a controlled substance, pharmacies can provide partial fills, and patients can transfer their prescription freely between pharmacies. This is an important practical advantage when a supply disruption occurs — patients are not legally restricted to a single pharmacy or limited in how they search for their medication.
Most common side effects are mild and tend to improve as the body adjusts. These include:
Dizziness
Headache
Nausea
Drowsiness/somnolence
Ataxia (uncoordinated movements)
Diplopia (double vision) or blurred vision
Vomiting
Serious side effects requiring prompt medical attention include:
Stevens-Johnson syndrome (SJS) / toxic epidermal necrolysis (TEN) — potentially fatal skin reaction [BOXED WARNING]
DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) — severe multiorgan allergic reaction
Suicidal thoughts or behavior (FDA class warning for all antiepileptics)
Aseptic meningitis
Blood disorders (neutropenia, anemia, aplastic anemia)
Cardiac arrhythmias (in patients with pre-existing structural or conduction heart defects — FDA warning 2021)
Know what you need? Skip the search.
Levetiracetam (Keppra)
SV2A-binding anticonvulsant; broad-spectrum; minimal drug interactions; very affordable as generic; may cause psychiatric side effects including irritability
Valproate / Divalproex (Depakote)
Broad-spectrum AED and mood stabilizer for acute mania; significant teratogenicity risk in women of childbearing potential; interacts with lamotrigine
Lithium (Lithobid)
Gold standard mood stabilizer for bipolar maintenance; comparable efficacy to lamotrigine for bipolar; requires blood level monitoring; not an anticonvulsant
Carbamazepine (Tegretol)
Classic sodium channel blocker for focal seizures and bipolar disorder; many drug interactions; significant enzyme inducer; affordable generic
Oxcarbazepine (Trileptal)
Better-tolerated relative of carbamazepine; effective for focal seizures; risk of hyponatremia; affordable generic
Topiramate (Topamax)
Broad-spectrum AED; weight neutral to weight-negative; cognitive side effects common; not used for bipolar disorder
Prefer Lamotrigine? We can find it.
Valproate / Valproic Acid (Depakote)
majorInhibits lamotrigine glucuronidation, approximately doubling lamotrigine blood levels. Requires lamotrigine dose reduction to ~50% of standard. Significantly increases risk of serious skin rash.
Carbamazepine (Tegretol)
majorEnzyme inducer that reduces lamotrigine levels by approximately 40-50%. Higher lamotrigine doses required. Level changes when carbamazepine is started or stopped.
Phenytoin (Dilantin)
majorStrong enzyme inducer; reduces lamotrigine levels significantly. Dose adjustment required.
Phenobarbital / Primidone
majorEnzyme inducers; reduce lamotrigine levels. Higher doses needed.
Rifampin
majorVery potent enzyme inducer; dramatically reduces lamotrigine levels. Alert prescriber immediately if prescribed rifampin for tuberculosis or other infections.
Estrogen-containing oral contraceptives
majorReduce lamotrigine levels by ~50%. Lamotrigine may also reduce contraceptive efficacy. Bidirectional interaction requiring dose adjustment and backup contraception.
Dofetilide (Tikosyn)
majorCombination is strongly discouraged due to severe cardiac arrhythmia risk. Considered contraindicated.
Lopinavir/ritonavir, Atazanavir/ritonavir (HIV protease inhibitors)
moderateReduce lamotrigine levels through enzyme induction. Dose adjustment required for patients on antiretroviral therapy.
Alcohol / CNS depressants
moderateAdditive CNS depression — increased drowsiness, dizziness, and coordination impairment.
St. John's Wort
moderateHerbal enzyme inducer; reduces lamotrigine levels and may reduce seizure or mood protection.
Lamotrigine is a cornerstone medication in neurology and psychiatry — one of the most prescribed drugs in the US for good reason. It offers a unique combination of broad-spectrum anticonvulsant efficacy and mood-stabilizing properties with a favorable tolerability profile, particularly its weight-neutral effect compared to valproate and lithium. The medication does carry important safety considerations, especially the mandatory slow titration to prevent serious skin reactions and the critical drug interaction profile that must be managed when adding or removing other medications.
From a cost perspective, lamotrigine is one of the most affordable long-term medications available. With proper use of generic formulations and discount programs, most patients should be paying under $15 per month. Supply continuity — not cost — is the more common practical challenge, particularly for less common formulations and in regions with limited independent pharmacy access.
If you're having difficulty filling your lamotrigine prescription, medfinder can quickly identify which pharmacies near you have your specific formulation and dose in stock, saving you valuable time and helping ensure your medication supply isn't interrupted.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards